ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

Proposed Surveillance Model Aims To Reduce Post-Treatment Pain

April 27, 2012

Bush Asks Hammer To Probe FDA Regulation Of Anticancer Drugs

June 17, 1988

Study Finds Trial Results Reliable At Three Years

July 29, 2005

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995